Clear cell and papillary serous endometrial carcinomas: Survival in a series of 128 cases

Archives of Gynecology and Obstetrics

Volumn 287, Issue 2, 2013, Pages 351-356

  Scarfone, Giovanna ^a   Secomandi, Rita ^a   Parazzini, Fabio ^a   Viganò, Riccardo ^b   Mangili, Giorgia ^b   Frigerio, Luigi ^c   Villa, Antonella ^c   Tateo, Saverio ^d   Ricci, Elena ^e   Bolis, Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e epi2004   (Italy)

Author keywords

Endometrial cancer; Histotype; Survival

Indexed keywords

ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CASE STUDY; CLEAR CELL CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; ITALY; MAJOR CLINICAL STUDY; PELVIS; PROGRESSION FREE SURVIVAL;

ADENOCARCINOMA, CLEAR CELL; AGED; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84878362322     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2586-x     Document Type: Article

References (24)

1. Abeler VM, Vergote IB, Kjorstad KE, Trope CG (1996) Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 78:1740-1747
2. Bristow RE, Asrari F, Trimble EL, Montz FJ (2001) Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease. Gynecol Oncol 81:279-286
3. Carcangiu ML, Chambers JT (1992) Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47:298-305
4. Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML (2003) Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol 90:181-185
5. Craighead PS, Sait K, Stuart GC, Arthur K, Nation J, Duggan M, Guo D (2000) Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994. Gynecol Oncol 77:248-253
6. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P (2004) Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 95:593-596
7. Eifel PJ, Ross J, Hendrickson M, Cox RS, Kempson R, Martinez A (1983) Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons. Cancer 52:1026-1031
8. Elit L, Kwon J, Bentley J, Trim K, Ackerman I, Carey M (2004) Optimal management for surgically stage 1 serous cancer of the uterus. Gynecol Oncol 92:240-246
9. Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, Gehrig PA, Tuller E, Axtell AE, Zanotti KM (2009) Platinum/taxanebased chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer 115:2119-2127
10. Gehrig PA, Groben PA, Fowler WC Jr, Walton LA, Van Le L (2001) Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol 97:153-157
11. Gehrig PA, Van Le L, Fowler WC Jr (2003) The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 13:212-215
12. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, Cain JM, Tamimi HK, Figge DC, Greer BE (1994) Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 54:264-268
13. Greggi S, Mangili G, Scaffa C, Scala F, Losito S, Iodice F, Pisano C, Montoli S, Vigano R, Pirozzi G, Giannarelli D (2011) Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study. Int J Gynecol Cancer 21:661-667
14. Grice J, Ek M, Greer B, Koh WJ, Muntz HG, Cain J, Tamimi H, Stelzer K, Figge D, Goff BA (1998) Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol 69:69-73
15. Huh WK, Powell M, Leath CA 3rd, Straughn JM Jr, Cohn DE, Gold MA, Falkner CA, Carey DE, Herzog T, Fowler JM, Partridge EE, Kilgore LC, Alvarez RD (2003) Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol 91:470-475
16. Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE (2004) Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecol Oncol 95:469-473
17. Mendivil A, Schuler KM, Gehrig PA (2009) Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 16:46-52
18. Petignat P, Usel M, Gauthier P, Popowski Y, Pelte MF, Bouchardy C, Verkooijen HM (2008) Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas. Eur J Gynaecol Oncol 29:57-60
19. Randall ME, Brunetto G, Muss H et al (2003) Whole abdominal radiotherapy versus combinationdoxorubicin-cisplatin chemotherapy in avanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. [Abstract]. Proc Am Soc. Clin Oncol 22:2
20. Rosenberg P, Blom R, Hogberg T, Simonsen E (1993) Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol 51:311-315
21. Shechter-Maor G, Bruchim I, Ben-Harim Z, Altaras M, Fishman A (2009) Combined chemotherapy regimen of carboplatin and paclitaxel as adjuvant treatment for papillary serous and clear cell endometrial cancer. Int J Gynecol Cancer 19:662-664
22. Steed H, Manchul L, Rosen B, Fyles A, Lockwood G, Laframboise S, Murphy J, Milosevic M, Chapman W, Oza AM (2006) Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy. Int J Gynecol Cancer 16(Suppl 1):278-285
23. Sutton GP, Brill L, Michael H, Stehman FB, Ehrlich CE (1987) Malignant papillary lesions of the endometrium. Gynecol Oncol 27:294-304
24. Zheng W, Schwartz PE (2005) Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol 96:579-582